Seres Therapeutics, Inc. (MCRB) › Capital ExpendituresSeres Therapeutics, Inc. (MCRB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $174.0K2014: $1.00M2015: $4.36M2016: $21.49M2017: $4.68M2018: $1.94M2019: $1.00M2020: $591.0K2021: $9.57M2022: $9.82M2023: $7.97M2024: $380.0K2025: $252.0K$252.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$252.0K-33.7%2024$380.0K-95.2%2023$7.97M-18.8%2022$9.82M+2.7%2021$9.57M+1518.6%2020$591.0K-41.0%2019$1.00M-48.3%2018$1.94M-58.6%2017$4.68M-78.2%2016$21.49M+392.7%2015$4.36M+335.8%2014$1.00M+475.3%2013$174.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share